Chemoembolization practice patterns and technical methods among interventional radiologists: Results of an online survey

American Journal of Roentgenology

Volumn 198, Issue 3, 2012, Pages 692-699

  Gaba, Ron C ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chemoembolization; Interventional radiology; Liver; Survey

Indexed keywords

BIOMATERIAL; CISPLATIN; DOXORUBICIN; GELATIN SPONGE; IODINATED POPPYSEED OIL; MICROSPHERE; MITOMYCIN; POLYMER; POLYVINYL ALCOHOL; POLYZENE F; SORAFENIB; UNCLASSIFIED DRUG; YTTRIUM 90;

ARTICLE; CHEMOEMBOLIZATION; CLINICAL DECISION MAKING; COMMUNITY HOSPITAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EMULSION; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; HYDROGEL; INTERVENTIONAL RADIOLOGY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; ONLINE ANALYSIS; OUTPATIENT CARE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; QUESTIONNAIRE; RADIOLOGIST; RETREATMENT; SEX RATIO; TREATMENT CONTRAINDICATION; UNITED STATES;

CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INTERNET; MALE; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RADIOGRAPHY, INTERVENTIONAL; SOCIETIES, MEDICAL;

EID: 84857866021     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7066     Document Type: Article

References (35)

1. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised con trolled trial. Lancet 2002; 359:1734-1739 (Pubitemid 34607087)
2. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171 (Pubitemid 34454013)
3. Breedis C, Young G. The blood supply of neoplasm of the liver. Am J Pathol 1954; 30:969-985
4. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JH. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13:S211-S221
5. Liapi E, Geschwind JH. Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? Cardiovasc Intervent Radiol 2011; 34:37-49
6. Tsochatzis EA, Germani G, Burroughs AK. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment. Semin Oncol 2010; 37:89-93
7. Chuang VP, Wallace S. Chemoembolization: transcatheter management of neoplasms. JAMA 1981; 245:1151-1152 (Pubitemid 11095966)
8. Schultheis KH. Chemoembolization: a new treatment for malignant tumors and metastases. Recent Results Cancer Res 1983; 86:46-47
9. Brown DB, Gould JE, Gervais DA, et al. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009; 20:S425-S434
10. Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 2009; 44(suppl 19):96-101
11. Salem R, Lewandowski RJ, Kulik L, et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2011; 140:497.e2-507.e2
12. Lammer J, Malagari K, Vogl T, et al.; PRECISION V Investigators. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010; 33:41-52
13. Namur J, Wassef M, Millot JM, Lewis AL, Manfait M, Laurent A. Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model. J Vasc Interv Radiol 2010; 21:259-267
14. Trojan J, Zeuzem S. To bead or not to bead: is transarterial chemoembolization with doxorubicin- eluting beads a new standard of care in hepatocellular carcinoma? Gastroenterology 2010; 139:690-692
15. Lewandowski RJ, Mulcahy MF, Kulik LM, et al. Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology 2010; 255:955-965
16. Malagari K, Pomoni M, Kelekis A, et al. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with Bead Block for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2010; 33:541-551
17. Marelli L, Stigliano R, Triantos C, et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007; 30:6-25 (Pubitemid 44900485)
18. Helmberger T. Interventional procedures for hepatic metastases [in German]. Chirurg 2010; 81:542-550
19. Hong K, McBride JD, Georgiades CS, et al. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol 2009; 20:360-367
20. Brown DB, Cardella JF, Sacks D, et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 2009; 20:S219-S226
21. Jordan O, Denys A, De Baere T, Boulens N, Doelker E. Comparative study of chemoembolization loadable beads: in vitro drug release and physical loading properties of DC Bead and HepaSphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol 2010; 21:1084-1090
22. Lee KH, Liapi E, Vossen JA, et al. Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol 2008; 19:1490-1496
23. Brown DB, Geschwind JF, Soulen MC, Millward SF, Sacks D. Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol 2006; 17:217-223 (Pubitemid 44341440)
24. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004; 127:S179-S188 (Pubitemid 39423386)
25. Rhee TK, Young JY, Larson AC, et al. Effect of transcatheter arterial embolization on levels of hypoxia inducible factor-1 alpha in rabbit VX2 liver tumors. J Vasc Interv Radiol 2007; 18:639-645 (Pubitemid 46661178)
26. Jin B, Wang D, Lewandowski RJ, et al. Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma. AJR 2011; 196:919-928
27. Carmi L, Georgiades C. Combination percutaneous and intraarterial therapy for the treatment of hepatocellular carcinoma: a review. Semin Intervent Radiol 2010; 27:296-301
28. Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y. Combined treatment, TACE and RF ablation, in HCC: preliminary results. Radiol Med (Torino) 2002; 104:412-420 (Pubitemid 36362660)
29. Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 2010; 116:5452-5460
30. Takaki H, Yamakado K, Uraki J, et al. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol 2009; 20:217-224
31. Riaz A, Miller FH, Kulik LM. Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma. JAMA 2010; 303:1062-1069
32. Forner A, Ayuso C, Varela M, et al. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 2009; 115:616-623
33. Riaz A, Lewandowski RJ, Kulik L. Radiologicpathologic correlation of hepatocellular carcinoma treated with chemoembolization. Cardiovasc Intervent Radiol 2010; 33:1143-1152
34. Riaz A, Ryu RK, Kulik LM. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol 2009; 27:5734-5742
35. Satake M, Uchida H, Arai Y, et al. Transcatheter arterial chemoembolization (TACE) with Lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan. Cardiovasc Intervent Radiol 2008; 31:756-761